Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01386775 · ClinicalTrials.gov registry record
Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia: Intrafamilial Variation
A clinical trial of Hypohidrotic Ectodermal Dysplasia, sponsored by Edimer Pharmaceuticals.
- Completed
- Registry status
- 64
- Enrollment target
- 1
- Study location
NCT01386775 is a study of Hypohidrotic Ectodermal Dysplasia that has completed, run by Edimer Pharmaceuticals. The registered enrollment target is 64 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01386775, a study of Hypohidrotic Ectodermal Dysplasia, has completed, sponsored by Edimer Pharmaceuticals.
- COMPLETED
- Registry status
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
This study in affected Hypohidrotic Ectodermal Dysplasia (HED) males and unaffected male controls, age 1 year and up, will use minimally invasive devices to image sweat ducts in intact skin, to measure stimulated sweat rate, and in a subset of subjects to collect clipped scalp hair samples for RNA analysis. This study is descriptive in nature and is intended to assess the ability to use innovative approaches to generate data from subjects over a wide age spectrum, with particular emphasis on phenotype variability between male siblings (same mutation).
Conditions Studied
Study Locations (1)
Illinois
- Hilton Garden Inn St. Louis Shiloh/O'Fallon - O'Fallon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2011-06 |
| Est. Completion | 2011-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01386775
The ClinicalTrials.gov registry entry for NCT01386775 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edimer Pharmaceuticals, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypohidrotic Ectodermal Dysplasia appearing as the primary indexed condition, and to 0 interventions.
NCT01386775 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT01386775 about?
NCT01386775 is a clinical study titled "Male Subjects Affected By Hypohidrotic Ectodermal Dysplasia: Intrafamilial Variation". This study in affected Hypohidrotic Ectodermal Dysplasia (HED) males and unaffected male controls, age 1 year and up, will use minimally invasive devices to image sweat ducts in intact skin, to measure stimulated sweat rate, and in a subset of subjects to collect clipped scalp hair samples for RNA a...
What is the current status of trial NCT01386775?
This trial is currently completed. The enrollment target is 64 participants. The study started on 2011-06. Estimated completion is 2011-09.
What conditions does trial NCT01386775 study?
This clinical trial studies the following conditions: Hypohidrotic Ectodermal Dysplasia.
Who is sponsoring clinical trial NCT01386775?
This trial is sponsored by Edimer Pharmaceuticals, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01386775 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.